Carlos A. Garberoglio

View Scopus Profile

Research activity per year

Education/Academic qualification

MD, National University of Rosario

… → 1973

Disciplines

Laboratory and Basic Science Research
Oncology
Surgery

4 Active
16 Finished

A clinical trial of adjuvant therapy comparing six cycles of 5-fluorouracil, epirubicin and cyclophosphamide (FEC) to four cycles of adriamycin and cyclophosphamide (AC), with or without celecoxib, in patients with node-negative breast cancer
Garberoglio, C. A.
-
1/1/04 → …
Project: Research project
Sentinel Lymph Node Working Group Data Acquisition Project
Garberoglio, C. A.
-
1/1/04 → …
Project: Research project
A phase III, adjuvant trial comparing three chemotherpay regiments in women with node-positive breast cancer: Docetaxel/Doxorubicin/Cyclophosphamide (TAC); Dose-Dense (DD) Doxorubicin/Cyclophosphamide followed by DD. Paclitaxel; (DD AC followed by DD P)
Garberoglio, C. A.
-
1/1/04 → …
Project: Research project
A phase III clinical trial comparing infusional 5-fluorouracil(5-FU), leucovorin, and oxaliplatin (mFOLFOX6). Every two weeks with bevacizumab to the same regimen without bevacizumab for the treatment of patients with resected stages II and III carcinoma.
Garberoglio, C. A.
-
1/1/04 → …
Project: Research project
A randomized trial of axillary node dissection in women with clinical T1 or T2 NO M0 breast cancer who have a positive sentinel node
Garberoglio, C. A.
-
1/1/04 → 1/1/04
Project: Research project

81 Article
64 Poster
5 Review article
2 Letter

Identification of Populations at Risk for “Choosing Un-Wisely”: A SEER Population-Based Study
Hong, M. J., Lum, S. S., Ji, L., Namm, J. P., Solomon, N. L., Garberoglio, C. & Vora, H., Oct 2023, In: American Surgeon. 89, 10, p. 4135-4141 7 p.
Research output: Contribution to journal › Article › peer-review
A phase II trial of gemcitabine and erlotinib followed by ChemoProton therapy plus capecitabine and oxaliplatin for locally advanced pancreatic cancer
Sanghvi, S. M., Coffman, A. R., Hsueh, C. T., Kang, J., Park, A., Solomon, N. L., Garberoglio, C. A., Reeves, M. E., Slater, J. D. & Yang, G. Y., Aug 2022, In: Journal of Gastrointestinal Oncology. 13, 4, p. 1989-1996 8 p.
Research output: Contribution to journal › Article › peer-review

Open Access
Redistribution of Outpatient Oncologic Surgical Specialty Referrals During COVID-19
Sutjiadi, B., McRae, J., Silva, T., Selleck, M., Reeves, M., Garberoglio, C. & Lum, S., Oct 2021, In: American Surgeon. 87, 10, p. 1656-1660 5 p.
Research output: Contribution to journal › Article › peer-review

Open Access
Gastric Cancer Peritoneal Carcinomatosis Risk Score
Ji, L., Selleck, M. J., Morgan, J. W., Xu, J., Babcock, B. D., Shavlik, D., Wall, N. R., Langridge, W. H., Lum, S. S., Garberoglio, C. A., Reeves, M. E., Solomon, N., Namm, J. P. & Senthil, M., Jan 1 2020, In: Annals of Surgical Oncology. 27, 1, p. 240-247 8 p.
Research output: Contribution to journal › Article › peer-review

Open Access
The Impact of Primary Tumor Surgery on Survival in HER2 Positive Stage IV Breast Cancer Patients in the Current Era of Targeted Therapy
Mudgway, R., Chavez de Paz Villanueva, C., Lin, A. C., Senthil, M., Garberoglio, C. A. & Lum, S. S., Aug 1 2020, In: Annals of Surgical Oncology. 27, 8, p. 2711-2720 10 p.
Research output: Contribution to journal › Article › peer-review

15 Membership of network
5 Membership of committee

Periop Steering Committee (LLU) (External organization)
Carlos A. Garberoglio (Member)
Jan 1 2012 → …
Activity: Membership › Membership of committee
Medical Staff Executive Committee. Loma Linda University Medical Center (External organization)
Carlos A. Garberoglio (Member)
Jan 1 2012 → …
Activity: Membership › Membership of committee
Transplant Oversight Committee (LLU) (External organization)
Carlos A. Garberoglio (Member)
Jan 1 2012 → …
Activity: Membership › Membership of committee
OR Committee, Loma Linda University Medical Center (External organization)
Carlos A. Garberoglio (Member)
Jan 1 2011 → …
Activity: Membership › Membership of committee
Editorial Board of Journal of Gastrointestinal Oncology (External organization)
Carlos A. Garberoglio (Member)
Jan 1 2010 → …
Activity: Membership › Membership of network

First Prize, Resident Research Competition, Society for Surgery of the Alimentary Tract: "Is Glucagon a Choleretic Hormone at Physiologic Blood Levels?" ( 5/1981 )
Garberoglio, Carlos A. (Recipient), 1981
Prize: Prize (including medals and awards)
First Prize, Tri-County Surgical Society: "Biliary disease affecting the last trimester of pregnancy." ( 5/2000 )
Garberoglio, Carlos A. (Recipient), 2000
Prize: Prize (including medals and awards)
First Prize, Tri-County Surgical Society: "Chest Wall Reconstruction." ( 5/1990 )
Garberoglio, Carlos A. (Recipient), 1990
Prize: Prize (including medals and awards)
Prize winning presentation, Chicago Society of Gastroenterology: "The Effect of Glucagon on Canine Bile Flow." ( 4/1981 )
Garberoglio, Carlos A. (Recipient), 1981
Prize: Prize (including medals and awards)
Prize Winning Presentation (Dr. Jennifer Weik): "The Gail Model Predicts Breast Cancer in Women with Suspicious Radiographic Lesions." Presented at the Sixth Annual Meeting of the American Society of Breast Surgeons, Los Angeles, CA ( 3/2005 )
Garberoglio, Carlos A. (Recipient), 2005
Prize: Prize (including medals and awards)

Carlos A. Garberoglio, MD

Personal profile

Related documents

Education/Academic qualification

Disciplines

A clinical trial of adjuvant therapy comparing six cycles of 5-fluorouracil, epirubicin and cyclophosphamide (FEC) to four cycles of adriamycin and cyclophosphamide (AC), with or without celecoxib, in patients with node-negative breast cancer

Sentinel Lymph Node Working Group Data Acquisition Project

A phase III, adjuvant trial comparing three chemotherpay regiments in women with node-positive breast cancer: Docetaxel/Doxorubicin/Cyclophosphamide (TAC); Dose-Dense (DD) Doxorubicin/Cyclophosphamide followed by DD. Paclitaxel; (DD AC followed by DD P)

A phase III clinical trial comparing infusional 5-fluorouracil(5-FU), leucovorin, and oxaliplatin (mFOLFOX6). Every two weeks with bevacizumab to the same regimen without bevacizumab for the treatment of patients with resected stages II and III carcinoma.

A randomized trial of axillary node dissection in women with clinical T1 or T2 NO M0 breast cancer who have a positive sentinel node

Identification of Populations at Risk for “Choosing Un-Wisely”: A SEER Population-Based Study

A phase II trial of gemcitabine and erlotinib followed by ChemoProton therapy plus capecitabine and oxaliplatin for locally advanced pancreatic cancer

Redistribution of Outpatient Oncologic Surgical Specialty Referrals During COVID-19

Gastric Cancer Peritoneal Carcinomatosis Risk Score

The Impact of Primary Tumor Surgery on Survival in HER2 Positive Stage IV Breast Cancer Patients in the Current Era of Targeted Therapy

Periop Steering Committee (LLU) (External organization)

Medical Staff Executive Committee. Loma Linda University Medical Center (External organization)

Transplant Oversight Committee (LLU) (External organization)

OR Committee, Loma Linda University Medical Center (External organization)

Editorial Board of Journal of Gastrointestinal Oncology (External organization)

First Prize, Resident Research Competition, Society for Surgery of the Alimentary Tract: "Is Glucagon a Choleretic Hormone at Physiologic Blood Levels?" ( 5/1981 )

First Prize, Tri-County Surgical Society: "Biliary disease affecting the last trimester of pregnancy." ( 5/2000 )

First Prize, Tri-County Surgical Society: "Chest Wall Reconstruction." ( 5/1990 )

Prize winning presentation, Chicago Society of Gastroenterology: "The Effect of Glucagon on Canine Bile Flow." ( 4/1981 )

Prize Winning Presentation (Dr. Jennifer Weik): "The Gail Model Predicts Breast Cancer in Women with Suspicious Radiographic Lesions." Presented at the Sixth Annual Meeting of the American Society of Breast Surgeons, Los Angeles, CA ( 3/2005 )

Carlos A. Garberoglio, MD

Personal profile

Related documents

Education/Academic qualification

Disciplines

Projects

Research output

Activities

Prizes